Document Detail


An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure.
MedLine Citation:
PMID:  2193839     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In an open, randomized, parallel group study lasting 8 weeks, nine males and nine females with mild congestive cardiac failure were initially treated daily with 20 mg frusemide/2.5 mg amiloride or 0.5 mg bumetanide/573 mg potassium chloride. In two patients receiving the frusemide combination and in one receiving the bumetanide combination, the daily dose was doubled after 2 weeks' treatment because of inadequate control of symptoms. Mild congestive cardiac failure symptoms (raised jugular venous pressure, oedema and dyspnoea at rest and on effort) were controlled in 9/10 patients receiving frusemide/amiloride but two patients receiving bumetanide/potassium chloride still had mild oedema after 8 weeks. Both treatments were well tolerated overall and there were no clinically significant changes in plasma electrolytes, although one patient treated with frusemide/amiloride was withdrawn due to adverse events.
Authors:
D Latta; V P Finnamore; K Dalton; S Allman
Related Documents :
6731329 - Göteborg metoprolol trial: tolerance.
15505119 - Management of hypertension in the very elderly patient.
3325229 - Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary h...
6823859 - Intermittent, continuous outpatient dobutamine infusion in the management of congestive...
16338449 - Adherence to candesartan and placebo and outcomes in chronic heart failure in the charm...
2676169 - Hemodynamic and clinical effects of captopril in patients with severe congestive heart ...
12808539 - Locked-in syndrome: improvement in the prognosis after an early intensive multidiscipli...
9386719 - Thoracoscopic debridement of empyema thoracis.
17666039 - Female sexual dysfunction in urogenital prolapse surgery: colposacropexy vs. hysterocol...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of international medical research     Volume:  18 Suppl 2     ISSN:  0300-0605     ISO Abbreviation:  J. Int. Med. Res.     Publication Date:  1990  
Date Detail:
Created Date:  1990-08-08     Completed Date:  1990-08-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0346411     Medline TA:  J Int Med Res     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  10B-16B     Citation Subset:  IM    
Affiliation:
Rorer Health Care Ltd, Eastbourne, East Sussex, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amiloride / therapeutic use*
Blood Pressure
Bumetanide / therapeutic use*
Diuretics / therapeutic use*
Drug Combinations / therapeutic use
Female
Furosemide / therapeutic use*
Heart Failure / drug therapy*,  physiopathology
Heart Rate
Humans
Male
Potassium Chloride / therapeutic use*
Questionnaires
Chemical
Reg. No./Substance:
0/Diuretics; 0/Drug Combinations; 2609-46-3/Amiloride; 28395-03-1/Bumetanide; 54-31-9/Furosemide; 7447-40-7/Potassium Chloride; 92522-90-2/frumil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A review of long-term safety data with buflomedil.
Next Document:  An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyc...